Journal Article Summary
The article investigates the potential anticancer effects of amlodipine, a medication primarily used for hypertension, on non-small cell lung cancer (NSCLC) cells. Lung cancer is a leading cause of cancer-related deaths globally, and overcoming resistance to chemotherapy is a significant challenge in treatment. The study aims to explore how amlodipine may alter the metabolism of lung cancer cells and enhance their sensitivity to chemotherapy, thus providing insights into new therapeutic strategies for managing this aggressive disease.
Researchers conducted experiments using two NSCLC cell lines, A549 and H1299, to assess the effects of amlodipine on cell viability, migration, and invasion. They employed various assays, including the MTT assay for cell viability and scratch wound-healing assays for migration, alongside metabolomics analysis to identify changes in cellular metabolites. The results indicated that amlodipine significantly reduced the proliferation of both cell lines in a dose-dependent manner, with IC50 values of approximately 23 µM for A549 and 25.66 µM for H1299. Additionally, amlodipine treatment decreased the migration and invasiveness of the cancer cells and led to significant alterations in several metabolites, suggesting that it may disrupt critical metabolic pathways involved in cancer progression.
Despite these promising findings, the study has limitations that should be considered. It did not include a positive control in the cell viability experiments, and the metabolomics analysis was performed on only one cell line, which may limit the generalizability of the results. Patients and caregivers should discuss these findings with healthcare professionals, particularly regarding the potential use of amlodipine in cancer treatment and its implications for existing therapies. Further research is needed to fully understand the mechanisms behind amlodipine's effects and to explore its role in enhancing chemotherapy sensitivity in lung cancer patients.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Alqudah Mohammad A Y, Yaseen Mahmoud M, Alzoubi Karem H, Al-Husein Belal A, Bardaweel Sanaa K, Abuhelwa Ahmad Y, Semreen Ahlam M, Zenati Ruba A, et al.. Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells. Drug Design, Development and Therapy 2025. DOI: 10.2147/DDDT.S484561. PMID: 39991087. PMCID: PMC11847429.
Featured Pill Pals Product
Amlodipine 10 mg Tablets --- 30 Count --- Ascend Pharma Labs --- Generic For Norvasc
Amlodipine 10 mg Tablets — 30 Count — Ascend Pharma Labs — Generic For Norvasc is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
